Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
22.02
+0.21 (0.94%)
At close: Sep 15, 2025, 4:00 PM EDT
22.29
+0.27 (1.25%)
After-hours: Sep 15, 2025, 4:21 PM EDT
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $2.95 billion as of September 15, 2025. Its market cap has increased by 92.95% in one year.
Market Cap
2.95B
Enterprise Value
2.80B
1-Year Change
92.95%
Ranking
Category
Stock Price
$22.02
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $2.95B, an increase of 68.81%. That is a compound annual growth rate of 12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.92B | 32.41% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |